GFAP and central nervous system cancer: These studies have used 2341 in addition to BRAFV600E mutated CDKN2ANull murine glioma cells derived from mice expressing BRAFV600E using the CRE/Lox system under the nestin and GFAP-promoter, as well as established cancer cell lines.